newsfilter
← Latest News
PR Newswire·

BIOVAXYS ANNOUNCES PROPOSED DEBT SETTLEMENT

VANCOUVER, B.C., July 4, 2022 /CNW/ - BioVaxys Technology Corp. (CSE:BIOV, FRA: 5LB, OTCQB:BVAXF) ("BioVaxys" or the "Company") announces that is proposing to settle an aggregate of approximately $497,000 in debt through the issuance of common shares to